Can Genomic Medicine Improve Financial Sustainability of Health Systems?

    loading  Checking for direct PDF access through Ovid

Abstract

Recent years have seen increased use of genomic technologies in a variety of research and clinical settings. Genomic medicine is not a cost-containment measure per se, but is viewed as having the potential to bend the healthcare cost curve. Currently, it is unknown how systematic adoption of genomic medicine in clinical practice will impact healthcare costs. This article discusses the potential economic impact of genomic medicine and the challenges that lie ahead.

Related Topics

    loading  Loading Related Articles